GenSight Biologics Reports its Cash Position as of March 31, 2019

GenSight Biologics completes a capital increase of €8 million without discount subscribed entirely by Sofinnova

GenSight Biologics Updates its 2019 Financial Calendar

BioEurope Spring, Vienna, Austria

GenSight Biologics Announces its 2019 Financial Calendar

GenSight Biologics Reports its Cash Position as of December 31, 2018

Oddo BHF Forum, Lyon, France

37th Annual J.P. Morgan Healthcare Conference, San Francisco (CA), USA

GenSight Biologics to participate in multiple upcoming investor conferences

Salon Actionaria 2018, Paris, France